Thomas B Casale is an expert in Allergy at University of South Florida (United States). As of October 2026, ScienceLeadR ranks Thomas B Casale in the top 1% of experts worldwide for Hypersensitivity, Rhinitis and Nose Diseases. Thomas B Casale has authored 698 publications, the most recent in 2026, and is an investigator in 20 clinical trials. SLR score: 2,775 (community average: 125). How the SLR is computed.

LeadR Profile

Thomas B Casale University of South Florida United States
2 775 ScienceLeadR Reputation 2775
Network Map

Allergy

Subspecialties: Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr Casale is Professor of Medicine and Pediatrics and Chief of Clinical and Translational Research at University of South Florida Division of Allergy and Immunology in Tampa. He is a Past President of the American Academy of Allergy Asthma and Immunology and was Executive Vice President for 10 years. He has served on the board of directors for the American Thoracic Society, The World Allergy Organization, and the American Board of Allergy and Immunology where he was also chair. Dr Casale was also Chief Medical Advisor, Food Allergy Research and Education (FARE) for 4 years. Dr Casale has worked on bench to bedside research with a special focus on biologics and translational research. He has published over 550 scientific papers, reviews, and chapters; organized and directed more than fifty CME programs; and been on planning committees for five World Asthma Meetings. He has been on the editorial boards of multiple journals including JACI and JACI Practice. He is recognized as one of the world’s top 2% most influential scientists by research.com.

Organizations

Career arc: 1987 - 2026

Source: PubMed

University of South Florida

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Steroid Sparing Effect of 300IR House Dust Mite Sublingual Immunotherapy Tablet in Mite Allergic Rhinitis.
PMID 42579775 — dust, sublingual immunotherapy, rhinitis, allergic, probability, tablets, immunotherapy, signs and symptoms, rhinitis, therapeutics, steroids
Clin Transl Allergy20260
Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations.
PMID 42410948 — probability, hypersensitivity, prescriptions, allergens, immunotherapy, motivation, physicians, rhinitis, asthma
Allergy20260
The Monoclonals: What have we learned and where are we going?
PMID 42119664 — antibodies, hypersensitivity, immunity, antibodies, monoclonal, therapeutics, asthma
Ann Allergy Asthma Immunol20260
Pragmatic Strategies for Reducing Variability and Risk in Food Oral Immunotherapy.
PMID 42115504 — hypersensitivity, allergens, immunotherapy, food
Clin Rev Allergy Immunol20260
Pirfenidone and its Derivative: Novel Bronchodilators and Leukocyte Airway Inflammation Inhibitors.
PMID 42089319 — bronchodilator agents, lung, bronchoconstrictor agents, myosins, molecular biology, adrenal cortex hormones, neutrophils, airway remodeling, leukocytes, therapeutics, asthma
Am J Respir Cell Mol Biol20260

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3 Study Chair: 1

By phase:

Phase 3 9
Phase 4 6
Phase 2 3
N/A 2

By status:

Completed 17
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 19
Observational 1

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 1
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map